Leserbrief
Orphan Blockbuster Drug Development: The Authors Reply
Health Affairs · 01.11.2026 · 45 (11) · 1308-1309
DOI: 10.1377/hlthaff.2026.01425 ↗Kurz gefasst
Leserbrief in der Zeitschrift Health Affairs, erschienen am 01.11.2026. Verfasst von Anna Kaltenboeck. Beteiligte Einrichtung: Anna Kaltenboeck, Verdant Research Oakton, Virginia. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Anna Kaltenboeck, Verdant Research Oakton, Virginia.
Zitieren
APA
Kaltenboeck, A. (2026). Orphan Blockbuster Drug Development: The Authors Reply. Health Affairs, 45(11), 1308-1309. https://doi.org/10.1377/hlthaff.2026.01425
Vancouver
Kaltenboeck A. Orphan Blockbuster Drug Development: The Authors Reply. Health Affairs. 2026;45(11):1308-1309. doi:10.1377/hlthaff.2026.01425
BibTeX
@article{Kaltenboeck2026,
author = {Kaltenboeck, Anna},
title = {Orphan Blockbuster Drug Development: The Authors Reply},
journal = {Health Affairs},
year = {2026},
volume = {45},
number = {11},
pages = {1308--1309},
doi = {10.1377/hlthaff.2026.01425}
}
EUVIMED